Protara Therapeutics, Inc.
NASDAQ:TARA
2.59 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -40.42 | -65.952 | -47.252 | -33.978 | -14.992 | -20.729 | -29.964 | -28.526 | -21.377 | -3.342 |
| Depreciation & Amortization
| 0.341 | 0.248 | 0.117 | 0.196 | 0.279 | 0.115 | 0.148 | 0.123 | 0.057 | 0.03 |
| Deferred Income Tax
| -0.848 | 0 | 0 | -9.94 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 6.092 | 6.688 | 10.362 | 9.746 | 0.943 | 3.429 | 0.001 | 3.343 | 2.164 | 0.459 |
| Change In Working Capital
| -4.139 | 0.539 | 0.534 | 0.629 | -1.872 | -5.972 | 4.412 | 1.293 | 0.327 | 0.109 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0.017 | 0.049 | -0.046 | -0.026 | -0.032 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | -0.017 | 0 | -41.791 | -63.522 | -83.489 | 0 |
| Accounts Payables
| 0.848 | 0.631 | 0.04 | 0.198 | -2.497 | -6.162 | 4.161 | 1.073 | 1.258 | 0.955 |
| Other Working Capital
| -4.987 | -0.092 | 0.494 | 0.431 | 0.625 | 0.19 | 4.458 | 1.319 | 0.359 | -0.846 |
| Other Non Cash Items
| 1.417 | 32.02 | 1.737 | 9.94 | -0.004 | -0.076 | 3.394 | 3.695 | 3.573 | -7.246 |
| Operating Cash Flow
| -37.557 | -26.457 | -34.502 | -23.407 | -15.646 | -23.233 | -22.352 | -23.687 | -17.566 | -9.99 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.045 | -0.12 | -0.596 | -0.884 | -0.016 | -0.119 | -0.035 | -0.271 | -0.198 | -0.051 |
| Acquisitions Net
| 0 | -0.015 | 0.098 | 3.719 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -12.186 | -43.55 | -124.748 | 0 | 0 | -15.443 | -32.942 | -39.756 | -88.644 | -34.95 |
| Sales Maturities Of Investments
| 65.338 | 58.62 | 27.15 | 0 | 2.5 | 33.989 | 16.878 | 59.943 | 77.511 | 22.518 |
| Other Investing Activites
| 0 | 0.015 | -0.098 | 3.719 | 0 | 0 | 0 | 0 | 2.006 | 0 |
| Investing Cash Flow
| 53.107 | 14.95 | -98.194 | 2.835 | 2.484 | 18.427 | -16.099 | 19.916 | -11.331 | -12.483 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | -1.669 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 87.85 | 0.5 | 2.853 | 1.526 | 0.208 | 0.163 | 62.485 |
| Common Stock Repurchased
| -0.091 | -0.09 | -0.228 | 0 | 0 | 0 | 23.049 | 0.208 | 0.163 | 88.972 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.091 | -0.09 | -0.228 | 103.22 | 0.001 | 0.132 | 21.523 | -0.011 | -0.075 | -62.937 |
| Financing Cash Flow
| -0.091 | -0.09 | -0.228 | 189.401 | 0.5 | 2.985 | 23.049 | 0.208 | 0.163 | 88.52 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | -0.5 | 0.022 | 0.18 | -0.076 | -0.075 | 0 |
| Net Change In Cash
| 15.459 | -11.597 | -132.924 | 168.829 | -13.162 | -1.799 | -15.222 | -3.639 | -28.809 | 66.047 |
| Cash At End Of Period
| 39.586 | 24.872 | 36.469 | 169.393 | 6.231 | 19.393 | 21.17 | 36.392 | 40.031 | 68.837 |